APA (7th ed.) Citation

R, A., RM, E., MIA, H., KM, D., AM, A., AB, K., & AM, F. (2022). Repurposing levocetirizine hydrochloride loaded into cationic ceramide/phospholipid composite (CCPCs) for management of alopecia: Central composite design optimization, in- silico and in-vivo studies. Drug delivery, 29(1), 2784. https://doi.org/10.1080/10717544.2022.2108939

Chicago Style (17th ed.) Citation

R, Albash, El-Dahmy RM, Hamed MIA, Darwish KM, Alahdal AM, Kassem AB, and Fahmy AM. "Repurposing Levocetirizine Hydrochloride Loaded into Cationic Ceramide/phospholipid Composite (CCPCs) for Management of Alopecia: Central Composite Design Optimization, in- Silico and In-vivo Studies." Drug Delivery 29, no. 1 (2022): 2784. https://doi.org/10.1080/10717544.2022.2108939.

MLA (9th ed.) Citation

R, Albash, et al. "Repurposing Levocetirizine Hydrochloride Loaded into Cationic Ceramide/phospholipid Composite (CCPCs) for Management of Alopecia: Central Composite Design Optimization, in- Silico and In-vivo Studies." Drug Delivery, vol. 29, no. 1, 2022, p. 2784, https://doi.org/10.1080/10717544.2022.2108939.